Manufacturing & marketing of a critical drug, developed under Technology Development Fund, for radiological & nuclear emergencies gets approval by Drugs Controller General of India (DCGI)
Read here: https://t.co/w0wKaPFNn7 @DefenceMinIndia— PIB India (@PIB_India) March 14, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


